Secondary hemophagocytic lymphohistiocytosis characterized by liver injury

Zeng, Zhan; Li, Minghui; Xie, Yao

doi:10.1016/j.medcli.2020.11.028

array:23 ["pii" => "S0025775320308472" "issn" => "00257753" "doi" => "10.1016/j.medcli.2020.11.028" "estado" => "S300" "fechaPublicacion" => "2021-12-10" "aid" => "5518" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2021;157:548-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "en" => array:18 [ "pii" => "S2387020621006069" "issn" => "23870206" "doi" => "10.1016/j.medcle.2020.11.035" "estado" => "S300" "fechaPublicacion" => "2021-12-10" "aid" => "5518" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2021;157:548-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Secondary hemophagocytic lymphohistiocytosis characterized by liver injury" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "548" "paginaFinal" => "549" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Linfohistiocitosis hemofagocítica secundaria con expresión fundamentalmente hepática" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2983 "Ancho" => 2497 "Tamanyo" => 387370 ] ] "descripcion" => array:1 [ "en" => "Routine blood test and liver function." ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Zhan Zeng, Minghui Li, Yao Xie" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Zhan" "apellidos" => "Zeng" ] 1 => array:2 [ "nombre" => "Minghui" "apellidos" => "Li" ] 2 => array:2 [ "nombre" => "Yao" "apellidos" => "Xie" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0025775320308472" "doi" => "10.1016/j.medcli.2020.11.028" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775320308472?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006069?idApp=UINPBA00004N" "url" => "/23870206/0000015700000011/v1_202112030828/S2387020621006069/v1_202112030828/en/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S0025775321000701" "issn" => "00257753" "doi" => "10.1016/j.medcli.2020.12.024" "estado" => "S300" "fechaPublicacion" => "2021-12-10" "aid" => "5578" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2021;157:550" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "Carta al Editor" "titulo" => "Arritmias ventriculares malignas en un paciente con síndrome de Gitelman" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "550" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Malignant ventricular arrhythmias in a patient with Gitelman syndrome" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Adrián Riaño Ondiviela, Daniel Meseguer González, Jose Ramón Ruiz Arroyo" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Adrián" "apellidos" => "Riaño Ondiviela" ] 1 => array:2 [ "nombre" => "Daniel" "apellidos" => "Meseguer González" ] 2 => array:2 [ "nombre" => "Jose Ramón" "apellidos" => "Ruiz Arroyo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020621006288" "doi" => "10.1016/j.medcle.2020.12.030" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006288?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775321000701?idApp=UINPBA00004N" "url" => "/00257753/0000015700000011/v1_202111210516/S0025775321000701/v1_202111210516/es/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S0025775320308484" "issn" => "00257753" "doi" => "10.1016/j.medcli.2020.11.029" "estado" => "S300" "fechaPublicacion" => "2021-12-10" "aid" => "5519" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Med Clin. 2021;157:547-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Primary cutaneous gamma-delta T-cell lymphoma mimicking clinical amyopathic dermatomyositis: A case report" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "547" "paginaFinal" => "548" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Linfoma cutáneo primario de células T gamma-delta que imita la dermatomiositis amiopática clínica: informe de un caso" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Haijun Ma, Jinghang Zhang, Minghao Guo" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Haijun" "apellidos" => "Ma" ] 1 => array:2 [ "nombre" => "Jinghang" "apellidos" => "Zhang" ] 2 => array:2 [ "nombre" => "Minghao" "apellidos" => "Guo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2387020621006070" "doi" => "10.1016/j.medcle.2020.11.036" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2387020621006070?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775320308484?idApp=UINPBA00004N" "url" => "/00257753/0000015700000011/v1_202111210516/S0025775320308484/v1_202111210516/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "Letter to the Editor" "titulo" => "Secondary hemophagocytic lymphohistiocytosis characterized by liver injury" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "548" "paginaFinal" => "549" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Zhan Zeng, Minghui Li, Yao Xie" "autores" => array:3 [ 0 => array:3 [ "nombre" => "Zhan" "apellidos" => "Zeng" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] ] ] 1 => array:4 [ "nombre" => "Minghui" "apellidos" => "Li" "email" => array:1 [ 0 => "wuhm2000@sina.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 2 => array:4 [ "nombre" => "Yao" "apellidos" => "Xie" "email" => array:1 [ 0 => "xieyao00120184@sina.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of Hepatology Division 2, Peking university Ditan Teaching Hospital, Beijing 100015, China" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Linfohistiocitosis hemofagocítica secundaria con expresión fundamentalmente hepática" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2983 "Ancho" => 2497 "Tamanyo" => 387370 ] ] "descripcion" => array:1 [ "en" => "Routine blood test and liver function." ] ] ] "textoCompleto" => "Hemophagocytic lymphohistiocytosis (HLH) is a clinical syndrome characterized by excessive proliferation of activated lymphocytes and histiocytes, but immune failure and high inflammatory response in multiple organs, also known as hemophagocytic syndrome. The disease progresses rapidly, the condition is dangerous and the prognosis is poor.<a class="elsevierStyleCrossRefs" href="#bib0030">1–3</a> The clinical manifestations are diversified and non-specific, and it is easy to be misdiagnosed.A married woman, 33 years old, she had taken 7 doses of traditional Chinese medicine from January 4 to January 11, 2017, about one month later, symptoms of asthenia, poor appetite and yellow urine appeared. She was later hospitalized in our hospital. Physical examination: 39.1°C, severe jaundice of bilateral sclera, paler eyelid conjunctiva, obvious tenderness and rebound pain in the whole abdomen, negative Murphy's sign, positive moving dullness, mild pitting edema in both lower limbs. She had a history of hypertension for 2 years, and was treated with captopril.We further performed several biochemical and imaging tests on her. Routine blood tests suggested the presence of anemia and leukopenia; liver function test suggested elevated transaminases, bilirubin, and decreased albumin. The changes in the patient's blood profile and liver function are shown in <a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>. Abdominal ultrasound revealed a large liver, diffuse liver disease, splenomegaly and ascites.<elsevierMultimedia ident="fig0005"></elsevierMultimedia>Considering the clinical manifestations and laboratory results of the patient, we consider that the patient may have acute infectious diseases or hematological diseases. Clinically, if patients have symptoms such as fever, blood cell reduction, hepatosplenomegaly and so on, we should be alert to the possibility of hemophagocytic syndrome.<a class="elsevierStyleCrossRef" href="#bib0035">2</a> We performed a bone marrow biopsy. Bone marrow aspiration showed that the diagnosis was highly suspicious of HLH hemophagocytic syndrome.Reviewing the course of disease development, we sorted out the diagnosis and treatment ideas, looking for the etiology of HLH, thinking as follows: The patient had taken Chinese medicine, a month later began to appear fatigue, anorexia, yellow urine, yellow eyes, dizziness and other symptoms. Chinese medicine may be the cause of HLH or the incentive to aggravate HLH. While the patient signed on admission on March 14, the peritoneal irritation was positive, and there was still abdominal infection, which may be the factor inducing or aggravating HLH.This is a patient whose liver function is seriously damaged for unknown reasons, young female, acute onset, rapid progress, history of taking Chinese medicine 1 month before the onset, the course already lasting a month, with progressive fatigue, anorexia, yellow urine, severe damage to liver function, and in the late course of high fever. Under thorough examination and symptomatic liver protection, anti-infection, supportive treatment, has excluded A, B, D and E viral hepatitis, EBV and CMV hepatitis, has excluded drug, alcoholic, fatty, autoimmune, hereditary hepatitis. The patient was diagnosed as HLH with fever, splenomegaly, peripheral blood cytopenia and abnormal increase of ferritin, combined with bone puncture pathological examination, and without excluding pure red cell aplasia. The patient's condition progresses rapidly, and the cause of HLH is unknown, which may be related to traditional Chinese medicine and abdominal infection. Our treatment continued, and she died two days after the diagnosis. The diagnosis and treatment of this patient provides us with ideas to deal with similar problems in clinical practice.In this case, the patient had an acute onset and rapid progression of the disease, and came to our hospital late, which only gave us two days for treatment, although the symptomatic support therapy such as anti-infection, hepatoprotective, and blood transfusion was given, but the results were not satisfactory. The patient's clinical manifestation of predominantly hepatic impairment increased the difficulty of diagnosis, which in turn led to a delay in treatment, while early recognition of HLH and timely treatment is the key to improving prognosis.<a class="elsevierStyleCrossRefs" href="#bib0045">4,5</a> From this case, we should draw conclusions. Firstly, took as little as possible Chinese medicine with unknown composition. Secondly, early use of powerful antibiotics to control abdominal infection. Thirdly, for patients with liver injury as the main manifestation, the thinking of diagnosis and treatment should be broadened, but not limited to liver disease. In addition to liver injury, when facing patients with fever, splenomegaly and other manifestations, we should consider other system diseases, especially blood system diseases." "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2983 "Ancho" => 2497 "Tamanyo" => 387370 ] ] "descripcion" => array:1 [ "en" => "Routine blood test and liver function." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0030" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in childhood inflammatory disorders: diagnosis and management" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L.A. Henderson" 1 => "R.Q. Cron" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s40272-019-00367-1" "Revista" => array:5 [ "tituloSerie" => "Paediatr Drugs" "fecha" => "2020" "volumen" => "22" "paginaInicial" => "29" "paginaFinal" => "44" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0035" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemophagocytic lymphohistiocytosis in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N.S. Bhatt" 1 => "B. Oshrine" 2 => "J. An Talano" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Leukemia Lymphoma" "fecha" => "2019" "volumen" => "60" "paginaInicial" => "19" "paginaFinal" => "28" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0040" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Sadaat" 1 => "S. Jang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/s40425-018-0365-3" "Revista" => array:5 [ "tituloSerie" => "J Immunother Cancer" "fecha" => "2018" "volumen" => "6" "paginaInicial" => "49" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29871698" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0045" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "How I treat hemophagocytic lymphohistiocytosis in the adult patient" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.M. Schram" 1 => "N. Berliner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1182/blood-2015-01-551622" "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "2015" "volumen" => "125" "paginaInicial" => "2908" "paginaFinal" => "2914" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25758828" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0050" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hemophagocytic lymphohistiocytosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Skinner" 1 => "B. Yankey" 2 => "B.K. Shelton" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "AACN Advanced Critical Care" "fecha" => "2019" "volumen" => "30" "paginaInicial" => "151" "paginaFinal" => "164" ] ] ] ] ] ] ] ] ] ] "agradecimientos" => array:1 [ 0 => array:4 [ "identificador" => "xack569230" "titulo" => "Acknowledgment" "texto" => "This study was funded in part by the National Science and Technology Major Project of China (2017ZX10201201-001-006 and 2017ZX10201201-002-006) and the Digestive Medical Coordinated Development Center of Beijing Hospitals Authority (XXZ0302)." "vista" => "all" ] ] ] "idiomaDefecto" => "en" "url" => "/00257753/0000015700000011/v1_202111210516/S0025775320308472/v1_202111210516/en/main.assets" "Apartado" => array:4 [ "identificador" => "66430" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Cartas al Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/00257753/0000015700000011/v1_202111210516/S0025775320308472/v1_202111210516/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0025775320308472?idApp=UINPBA00004N"]

ISSN: 0025-7753

Medicina Clínica, fundada en 1943, es la única publicación semanal de contenido clínico que se edita en España y constituye el máximo exponente de la calidad y pujanza de la medicina española. Son características fundamentales de esta publicación el rigor científico y metodológico de sus artículos, la actualidad de los temas y, sobre todo, su sentido práctico, buscando siempre que la información sea de la mayor utilidad en la práctica clínica. Los contenidos de Medicina Clínica abarcan dos frentes: trabajos de investigación original rigurosamente seleccionados atendiendo a su calidad, originalidad e interés, y trabajos orientados a la formación continuada, encomendados por la revista a autores relevantes (Editoriales, Revisiones, Conferencias clínicas y clínico-patológicas, Diagnóstico y Tratamiento). En estos artículos se ponen al día aspectos de destacado interés clínico o conceptual en la medicina actual. Medicina Clínica es un vehículo de información científica de reconocida calidad, como demuestra su inclusión en los más prestigiosos y selectivos índices bibliográficos del mundo.

Ver más Opción Open Access

Indexada en:

Current Contents/Clinical Medicine, Journal Citation Reports, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, MEDES, PASCAL, SCOPUS, ScienceDirect